TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA

This adverse event was reported 656 times

These drugs are most commonly taken by patients reporting TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA:

# Drug Count
0 AZACITIDINE 143
1 RUXOLITINIB 74
2 AZACITIDINE FOR 71
3 LENALIDOMIDE 61
4 CYTARABINE 59
5 DARBEPOETIN ALFA 56
6 BLINATUMOMAB 55
7 VENETOCLAX 52
8 CYCLOPHOSPHAMIDE 43
9 CYCLOPHOSPHAMIDE FOR INJECTION 43
See all common drugs associated with TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA

TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LUSPATERCEPT 38 0.0145
1 BLINATUMOMAB 55 0.0051
2 CHLORAMBUCIL 20 0.0051
3 CARMUSTINE 23 0.0049
4 AZACITIDINE 143 0.0047
5 (DAUNORUBICIN AND CYTARABINE) LIPOSOME 11 0.0045
6 CEDAZURIDINE AND DECITABINE 4 0.0041
7 MOMELOTINIB 6 0.0041
8 IDARUBICIN HYDROCHLORIDE 3 0.0026
9 IDECABTAGENE VICLEUCEL 3 0.0024
See all drugs enriched for association with TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA